Results 141 to 150 of about 437,591 (276)
Experiences and Perspectives on Diabetic Retinopathy Screening and Treatment in Mexico: A Subanalysis of the Diabetic Retinopathy Barometer Study. [PDF]
Pita-Ortiz IY +4 more
europepmc +1 more source
Abstract Purpose Proliferative diabetic retinopathy (PDR) is one of the leading causes of blindness in working‐age adults. We have previously shown that the risk of PDR is significantly elevated in individuals with intrauterine exposure to famine. However, the genetic mechanisms mediating this association remain unknown.
Olena Fedotkina +7 more
wiley +1 more source
Low‐contrast visual acuity versus low‐luminance visual acuity in choroideremia
Clinical relevance Choroideremia is a progressive X‐linked inherited rod‐cone dystrophy. Patients present with nyctalopia and progressive visual field loss, but visual acuity remains well preserved early on. This study showed that low‐luminance visual acuity may be a useful clinical outcome measure during earlier disease stages.
Laura J Wood +6 more
wiley +1 more source
Abstract To identify, describe and critically appraise studies developing and/or validating models for predicting sight‐threatening retinopathy of prematurity (ROP) in preterm infants undergoing screening in neonatal intensive care units. PubMed, Embase via Ovid, trial registers, and grey literature were searched from inception to 21 October 2025 ...
Stella Moutzouri +7 more
wiley +1 more source
Toward Reliable Diabetic Retinopathy Screening. [PDF]
Bragança H +5 more
europepmc +1 more source
Prevalence of diabetic retinopathy at Parirenyatwa hospital
BACKGROUND: There is a global epidemic of diabetes mellitus. Diabetes mellitus causes a myriad of microvascular and macrovascular complications. Diabetic retinopathy is one of the main microvascular complications. It is preventable.
Maboreke, Nyasha Phanuel
core
Three years of ocular proton therapy in the Netherlands, clinical results
Abstract Purpose Uveal melanoma (UM) is a rare cancer with rising number of diagnosis (143 diagnoses in 1990 to 226 in 2023) in the Netherlands. Most patients are treated locally with Ruthenium‐106 brachytherapy (±102/year). Patients were referred for proton therapy (PT) to Switzerland in the past, but PT is available in the Netherlands from January ...
C. Rasch +14 more
wiley +1 more source
Lipoxin A 4 (LXA 4 ) for diabetic retinopathy (DR). [PDF]
Das UN.
europepmc +1 more source
Abstract Purpose Early diagnosis of macular telangiectasia type 2 (MacTel) remains challenging, and the contribution of genetic variation to its clinical heterogeneity is unclear. This study investigated associations between MacTel risk variants and clinical characteristics in a Slovenian cohort.
Ajda Kunčič +4 more
wiley +1 more source
Association of vitamin D3 and diabetic retinopathy in US adults: A cross-sectional study. [PDF]
Qin M +4 more
europepmc +1 more source

